ArticleNeurology and therapy2024

Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis.

Pierre Clavelou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.